Nanox Imaging is trading at $0.37, down 10.09%, with no clear October 21 company-specific catalyst identified in available coverage.
- The latest disclosed update, on October 16, put preliminary Q3 revenue at $4.3–$4.4 million. Management said cash was insufficient for at least one year of operations, raising substantial doubt about the company’s ability to continue as a going concern.
- Healthcare was reportedly higher, so sector strength does not explain the decline.